Michael J Cawley1, William J Warning2. 1. Department of Pharmacy Practice and Pharmacy Administration, Philadelphia College of Pharmacy, University of the Sciences, 600 South 43rd Street, Philadelphia, PA, 19104-4495, USA. m.cawley@usciences.edu. 2. Family Medicine Residency Program, Crozer-Keystone Center for Family Health, Springfield, PA, USA.
Abstract
BACKGROUND: The scope of pharmacist services for patients with pulmonary disease has primarily focused on drug related outcomes; however pharmacists have the ability to broaden the scope of clinical services by performing diagnostic testing including quality spirometry testing. Studies have demonstrated that pharmacists can perform quality spirometry testing based upon international guidelines. AIM OF THE REVIEW: The primary aim of this review was to assess the published evidence of pharmacists performing quality spirometry testing based upon American Thoracic Society/European Respiratory Society (ATS/ERS) guidelines. In order to accomplish this, the description of evidence and type of outcome from these services were reviewed. METHODS: A literature search was conducted using five databases [PubMed (1946-January 2015), International Pharmaceutical Abstracts (1970 to January 2015), Cumulative Index of Nursing and Allied Health Literature, Cochrane Central Register of Controlled Trials and Cochrane Database of Systematic Reviews] with search terms including pharmacy, spirometry, pulmonary function, asthma or COPD was conducted. Searches were limited to publications in English and reported in humans. In addition, Uniform Resource Locators and Google Scholar searches were implemented to include any additional supplemental information. RESULTS: Eight studies (six prospective multi-center trials, two retrospective single center studies) were included. Pharmacists in all studies received specialized training in performing spirometry testing. Of the eight studies meeting inclusion and exclusion criteria, 8 (100%) demonstrated acceptable repeatability of spirometry testing based upon standards set by the ATS/ERS guidelines. Acceptable repeatability of seven studies ranged from 70 to 99% consistent with published data. CONCLUSION: Available evidence suggests that quality spirometry testing can be performed by pharmacists. More prospective studies are needed to add to the current evidence of quality spirometry testing performed by pharmacists and to measure health outcomes of the pulmonary patient.
BACKGROUND: The scope of pharmacist services for patients with pulmonary disease has primarily focused on drug related outcomes; however pharmacists have the ability to broaden the scope of clinical services by performing diagnostic testing including quality spirometry testing. Studies have demonstrated that pharmacists can perform quality spirometry testing based upon international guidelines. AIM OF THE REVIEW: The primary aim of this review was to assess the published evidence of pharmacists performing quality spirometry testing based upon American Thoracic Society/European Respiratory Society (ATS/ERS) guidelines. In order to accomplish this, the description of evidence and type of outcome from these services were reviewed. METHODS: A literature search was conducted using five databases [PubMed (1946-January 2015), International Pharmaceutical Abstracts (1970 to January 2015), Cumulative Index of Nursing and Allied Health Literature, Cochrane Central Register of Controlled Trials and Cochrane Database of Systematic Reviews] with search terms including pharmacy, spirometry, pulmonary function, asthma or COPD was conducted. Searches were limited to publications in English and reported in humans. In addition, Uniform Resource Locators and Google Scholar searches were implemented to include any additional supplemental information. RESULTS: Eight studies (six prospective multi-center trials, two retrospective single center studies) were included. Pharmacists in all studies received specialized training in performing spirometry testing. Of the eight studies meeting inclusion and exclusion criteria, 8 (100%) demonstrated acceptable repeatability of spirometry testing based upon standards set by the ATS/ERS guidelines. Acceptable repeatability of seven studies ranged from 70 to 99% consistent with published data. CONCLUSION: Available evidence suggests that quality spirometry testing can be performed by pharmacists. More prospective studies are needed to add to the current evidence of quality spirometry testing performed by pharmacists and to measure health outcomes of the pulmonary patient.
Entities:
Keywords:
Literature review; Pharmacist; Pharmacy services; Pulmonary function testing; Spirometry
Authors: Christopher J Licskai; Todd W Sands; Lisa Paolatto; Ivan Nicoletti; Madonna Ferrone Journal: Can Respir J Date: 2012 Jul-Aug Impact factor: 2.409
Authors: Daniel T Kennedy; Daniel M Paulson; Tia D Eddy; Pinki C Patel; Anuprita D Patkar; David A Holdford; Vera Y Genina; Erin N Griffin Journal: Pharmacotherapy Date: 2004-10 Impact factor: 4.705
Authors: Meilan K Han; Min Gayles Kim; Russell Mardon; Phil Renner; Sean Sullivan; Gregory B Diette; Fernando J Martinez Journal: Chest Date: 2007-06-05 Impact factor: 9.410
Authors: Barbara P Yawn; Paul L Enright; Robert F Lemanske; Elliot Israel; Wilson Pace; Peter Wollan; Homer Boushey Journal: Chest Date: 2007-06-05 Impact factor: 9.410
Authors: M Caminati; L Cegolon; M Bacchini; N Segala; A Dama; C Bovo; B Olivieri; F Furci; G Senna Journal: BMC Public Health Date: 2021-01-05 Impact factor: 3.295
Authors: Thys van der Molen; Job F M van Boven; Terence Maguire; Pankaj Goyal; Pablo Altman Journal: Br J Clin Pharmacol Date: 2016-11-02 Impact factor: 4.335